NDC 77530-725

Trudhesa

Dihydroergotamine Mesylate

Trudhesa is a Nasal Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Impel Pharmaceuticals Inc.. The primary component is Dihydroergotamine Mesylate.

Product ID77530-725_07e234fc-6c12-4c57-a6ac-1988b0edbfd2
NDC77530-725
Product TypeHuman Prescription Drug
Proprietary NameTrudhesa
Generic NameDihydroergotamine Mesylate
Dosage FormSpray, Metered
Route of AdministrationNASAL
Marketing Start Date2021-09-24
Marketing CategoryNDA /
Application NumberNDA213436
Labeler NameImpel Pharmaceuticals Inc.
Substance NameDIHYDROERGOTAMINE MESYLATE
Active Ingredient Strength4 mg/mL
Pharm ClassesErgotamine Derivative [EPC], Ergotamines [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 77530-725-00

1 VIAL, GLASS in 1 CARTON (77530-725-00) > 1 mL in 1 VIAL, GLASS
Marketing Start Date2021-09-24
NDC Exclude FlagN
Sample Package?Y

Drug Details

NDC Crossover Matching brand name "Trudhesa" or generic name "Dihydroergotamine Mesylate"

NDCBrand NameGeneric Name
77530-725TrudhesaDihydroergotamine mesylate
66490-041D.H.E. 45Dihydroergotamine Mesylate
0143-9273Dihydroergotamine MesylateDihydroergotamine Mesylate
0574-0850Dihydroergotamine MesylateDihydroergotamine Mesylate
0574-0851dihydroergotamine mesylatedihydroergotamine mesylate
24201-463Dihydroergotamine MesylateDihydroergotamine Mesylate
25021-609dihydroergotamine mesylatedihydroergotamine mesylate
61990-0411Dihydroergotamine MesylateDihydroergotamine Mesylate
68682-357Dihydroergotamine Mesylatedihydroergotamine mesylate
81284-411Dihydroergotamine MesylateDihydroergotamine Mesylate
82454-0411Dihydroergotamine MesylateDihydroergotamine Mesylate
70529-030DromelateDihydroergotamine Mesylate
0187-0245Migranaldihydroergotamine mesylate

Trademark Results [Trudhesa]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRUDHESA
TRUDHESA
90885069 not registered Live/Pending
Impel NeuroPharma, Inc.
2021-08-16
TRUDHESA
TRUDHESA
88578186 not registered Live/Pending
Impel NeuroPharma, Inc.
2019-08-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.